Pharming Group N.V. Gross Profit
Pharming Group N.V. (PHAR) reported Gross Profit of $330.63 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Income Statement
ifrs-full:GrossProfit · last filed 2026-04-02
EUR
| Period end | Gross Profit 12 month |
|---|---|
| 2020-12-31 | 165.09M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 147.67M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 112.95M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Gross Profit 12 month |
|---|---|
| 2025-12-31 | $330.63M 20-F · filed 2026-04-02 |
| 2024-12-31 | $261.80M 20-F · filed 2026-04-02 |
| 2023-12-31 | $220.10M 20-F · filed 2026-04-02 |
| 2022-12-31 | $188.06M 20-F · filed 2025-04-03 |
| 2021-12-31 | $177.73M 20-F · filed 2024-04-04 |
| 2020-12-31 | $188.63M 20-F · filed 2023-04-05 |
| 2019-12-31 | $165.46M 20-F · filed 2022-04-06 |